
    
      This is a randomized, open label trial comparing effectiveness of insulin glargine and
      insulin NPH in a basal plus correctional regimen. Patients will be randomized to either an
      intervention (NPH) or a control group (glargine) upon admission. The following data will be
      collected: age, sex, weight, preadmission diabetes medications, admission diagnosis, HbA1C,
      blood glucose (BG), chemistry, hematology, urine analysis, pregnancy test, duration of
      hospitalization, insulin dose, and discharge status. Data will be recorded and maintained
      confidentially.
    
  